


Scientists from the Center for Genetic Engineering and Biotechnology (CIGB) together with researchers from the Cuban health system have been developing for a decade a promising vaccine candidate HeberSaVax to guarantee the survival of patients with liver cancer or hepatocarcinoma, a pathology that annually causes more than half a million deaths worldwide.
Read more HeberSaVax: Another achievement of Cuban biotechnologyFive years ago, the visit of a president of the United States for the first time in more than eight decades seemed to indicate that the two countries were finally finding a way to coexistence.
Read more Cuba and US on the path to coexistencePage 130 of 487